id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0002-0158,FDA,FDA-2011-N-0002,Preparation for International Conference on Harmonization Regional Public Meeting - Transcript,Other,Transcript(s),2012-04-17T04:00:00Z,2012,4,2012-04-17T04:00:00Z,,2012-04-17T15:31:13Z,,0,0,0900006480ff26d4
FDA-2011-N-0002-0157,FDA,FDA-2011-N-0002,International Conference on Harmonization ICH Regional Public Meeting - Transcript,Other,Transcript(s),2012-04-16T04:00:00Z,2012,4,2012-04-16T04:00:00Z,,2012-04-17T15:35:06Z,,0,0,0900006480ff1eeb
FDA-2011-N-0002-0156,FDA,FDA-2011-N-0002,Workshops: Ethical and Regulatory Challenges in the Development of Pediatric Medical Countermeasures,Notice,Meeting,2012-01-18T05:00:00Z,2012,1,2012-01-18T05:00:00Z,,2012-07-02T12:58:09Z,2012-00846,0,0,0900006480f9946b
FDA-2011-N-0002-0153,FDA,FDA-2011-N-0002,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,,2011-12-30T14:13:50Z,2011-33552,0,0,0900006480f8b71a
FDA-2011-N-0002-0155,FDA,FDA-2011-N-0002,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,,2011-12-30T14:38:03Z,2011-33548,0,0,0900006480f8b7c4
FDA-2011-N-0002-0154,FDA,FDA-2011-N-0002,Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,,2011-12-30T14:26:10Z,2011-33561,0,0,0900006480f8b74c
FDA-2011-N-0002-0152,FDA,FDA-2011-N-0002,"Meetings: Cellular, Tissue, and Gene Therapies Advisory Committee",Notice,Meeting,2011-12-28T05:00:00Z,2011,12,2011-12-28T05:00:00Z,,2011-12-28T20:10:31Z,2011-33220,0,0,0900006480f8a239
FDA-2011-N-0002-0151,FDA,FDA-2011-N-0002,Requests for Nominations: Voting Members on Public Advisory Panels or Committees,Notice,General Notice,2011-12-27T05:00:00Z,2011,12,2011-12-27T05:00:00Z,,2011-12-27T16:38:57Z,2011-33060,0,0,0900006480f898b3
FDA-2011-N-0002-0150,FDA,FDA-2011-N-0002,Requests for Nominations: Food Advisory Committee Voting Members,Notice,General Notice,2011-12-27T05:00:00Z,2011,12,2011-12-27T05:00:00Z,,2011-12-27T16:32:38Z,2011-33108,0,0,0900006480f89874
FDA-2011-N-0002-0149,FDA,FDA-2011-N-0002,Endocrinologic and Metabolic Drugs Advisory Committee Meeting,Notice,Meeting,2011-12-27T05:00:00Z,2011,12,2011-12-27T05:00:00Z,,2011-12-27T16:27:31Z,2011-33059,0,0,0900006480f89822
FDA-2011-N-0002-0148,FDA,FDA-2011-N-0002,"Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice; Public Workshop",Notice,Meeting,2011-12-20T05:00:00Z,2011,12,2011-12-20T05:00:00Z,,2011-12-20T16:34:16Z,2011-32435,0,0,0900006480f864d2
FDA-2011-N-0002-0147,FDA,FDA-2011-N-0002,Advisory Committees Meeting,Notice,General Notice,2011-12-20T05:00:00Z,2011,12,2011-12-20T05:00:00Z,,2011-12-20T14:30:40Z,2011-32469,0,0,0900006480f86432
FDA-2011-N-0002-0145,FDA,FDA-2011-N-0002,Anesthetic and Analgesic Drug Products Advisory Committee Meeting,Notice,Meeting,2011-12-16T05:00:00Z,2011,12,2011-12-16T05:00:00Z,,2011-12-16T18:16:47Z,2011-32206,0,0,0900006480f84680
FDA-2011-N-0002-0146,FDA,FDA-2011-N-0002,Pediatric Advisory Committee Meeting,Notice,Meeting,2011-12-16T05:00:00Z,2011,12,2011-12-16T05:00:00Z,,2011-12-16T18:22:13Z,2011-32205,0,0,0900006480f8475c
FDA-2011-N-0002-0143,FDA,FDA-2011-N-0002,"Nominations for Voting Members on Public Advisory Committee, Science Board",Notice,General Notice,2011-11-28T05:00:00Z,2011,11,2011-11-28T05:00:00Z,,2011-11-28T14:19:43Z,2011-30415,0,0,0900006480f743ed
FDA-2011-N-0002-0144,FDA,FDA-2011-N-0002,Science Board to the Food and Drug Administration Meeting,Notice,Meeting,2011-11-28T05:00:00Z,2011,11,2011-11-28T05:00:00Z,,2011-11-28T14:25:12Z,2011-30416,0,0,0900006480f743bc
FDA-2011-N-0002-0142,FDA,FDA-2011-N-0002,Tobacco Products Scientific Advisory Committee; Notice of Meeting,Notice,Meeting,2011-11-23T05:00:00Z,2011,11,2011-11-23T05:00:00Z,,2011-11-23T14:55:39Z,2011-30163,0,0,0900006480f7209e
FDA-2011-N-0002-0141,FDA,FDA-2011-N-0002,Gastroenterology and Urology Devices Panel of Medical Devices Advisory Committee Meeting,Notice,Meeting,2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2011-11-21T14:52:52Z,2011-29890,0,0,0900006480f70957
FDA-2011-N-0002-0140,FDA,FDA-2011-N-0002,Meetings: Neurological Devices Panel of the Medical Devices Advisory Committee,Notice,Meeting,2011-11-16T05:00:00Z,2011,11,2011-11-16T05:00:00Z,,2011-11-16T22:17:24Z,2011-29528,0,0,0900006480f6d6f4
FDA-2011-N-0002-0139,FDA,FDA-2011-N-0002,Advisory Committee for Reproductive Health Drugs Meeting,Notice,Meeting,2011-11-14T05:00:00Z,2011,11,2011-11-14T05:00:00Z,,2011-11-14T14:34:30Z,2011-29181,0,0,0900006480f6bc37
FDA-2011-N-0002-0138,FDA,FDA-2011-N-0002,Meetings: Development and Evaluation of Human Cytomegalovirus Vaccines; Workshop,Notice,Public Meetings,2011-11-09T05:00:00Z,2011,11,2011-11-09T05:00:00Z,,2011-11-09T19:56:54Z,2011-29006,0,0,0900006480f68d19
FDA-2011-N-0002-0137,FDA,FDA-2011-N-0002,Bridging the Idea Development Evaluation Assessment and Long-Term Initiative and Total Product Life Cycle Approaches for Evidence Development for Surgical Medical Devices and Procedures: Public Workshop,Notice,Meeting,2011-11-07T05:00:00Z,2011,11,2011-11-07T05:00:00Z,2012-01-07T04:59:59Z,2012-01-20T19:13:57Z,2011-28722,0,0,0900006480f67079
FDA-2011-N-0002-0135,FDA,FDA-2011-N-0002,"Requests for Nominations, etc.: Nonvoting Industry Representatives, National Mammography Quality Assurance Advisory Committees",Notice,General Notice,2011-11-01T04:00:00Z,2011,11,2011-11-01T04:00:00Z,,2011-11-01T14:48:49Z,2011-28223,0,0,0900006480f63d19
FDA-2011-N-0002-0136,FDA,FDA-2011-N-0002,"Requests for Nominations, etc.: Nonvoting Industry Representatives, Public Advisory Panels",Notice,General Notice,2011-11-01T04:00:00Z,2011,11,2011-11-01T04:00:00Z,,2011-11-01T14:53:49Z,2011-28224,0,0,0900006480f63d34
FDA-2011-N-0002-0133,FDA,FDA-2011-N-0002,Oncologic Drugs Advisory Committee Meeting,Notice,Meeting,2011-10-24T04:00:00Z,2011,10,2011-10-24T04:00:00Z,,2011-10-24T14:00:36Z,2011-27327,0,0,0900006480f5a058
FDA-2011-N-0002-0134,FDA,FDA-2011-N-0002,Psychopharmacologic Drugs Advisory Committee Meeting,Notice,Meeting,2011-10-24T04:00:00Z,2011,10,2011-10-24T04:00:00Z,,2011-10-24T14:05:23Z,2011-27326,0,0,0900006480f5a0dc
FDA-2011-N-0002-0132,FDA,FDA-2011-N-0002,General and Plastic Surgery Devices Panel of Medical Devices Advisory Committee; Notice Postponement of Meeting,Notice,General Notice,2011-10-20T04:00:00Z,2011,10,2011-10-20T04:00:00Z,,2011-10-20T13:12:18Z,2011-27209,0,0,0900006480f56ac1
FDA-2011-N-0002-0131,FDA,FDA-2011-N-0002,"Meetings: Cellular, Tissue and Gene Therapies Advisory Committee",Notice,Meeting,2011-10-19T04:00:00Z,2011,10,2011-10-19T04:00:00Z,,2011-10-19T20:21:14Z,2011-27038,0,0,0900006480f55c76
FDA-2011-N-0002-0130,FDA,FDA-2011-N-0002,Science Advisory Board to the National Center for Toxicological Research Meeting,Notice,Meeting,2011-10-18T04:00:00Z,2011,10,2011-10-18T04:00:00Z,,2011-10-18T13:45:03Z,2011-26891,0,0,0900006480f54e03
FDA-2011-N-0002-0128,FDA,FDA-2011-N-0002,Joint Meeting of the Drug Safety and Risk Management Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee: Meetings,Notice,Meeting,2011-10-14T04:00:00Z,2011,10,2011-10-14T04:00:00Z,,2011-10-14T13:57:37Z,2011-26588,0,0,0900006480f52346
FDA-2011-N-0002-0129,FDA,FDA-2011-N-0002,Circulatory System Devices Panel of the Medical Devices Advisory Committee: Meetings,Notice,Meeting,2011-10-14T04:00:00Z,2011,10,2011-10-14T04:00:00Z,,2011-10-14T13:59:30Z,2011-26558,0,0,0900006480f52421
FDA-2011-N-0002-0127,FDA,FDA-2011-N-0002,Data Needs to Advance Risk Assessment for Infectious Diseases Relevant to Blood and Blood Products,Notice,Public Meetings,2011-10-12T04:00:00Z,2011,10,2011-10-12T04:00:00Z,,2011-10-12T13:51:03Z,2011-26295,0,0,0900006480f50f6f
FDA-2011-N-0002-0125,FDA,FDA-2011-N-0002,Antiviral Drugs Advisory Committee: Meetings,Notice,Meeting,2011-10-07T04:00:00Z,2011,10,2011-10-07T04:00:00Z,,2011-10-07T13:52:14Z,2011-25976,0,0,0900006480f4e69d
FDA-2011-N-0002-0126,FDA,FDA-2011-N-0002,General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee: Meetings,Notice,Meeting,2011-10-07T04:00:00Z,2011,10,2011-10-07T04:00:00Z,,2011-10-07T13:51:25Z,2011-25969,0,0,0900006480f4e6e1
FDA-2011-N-0002-0124,FDA,FDA-2011-N-0002,Meetings: Pediatric Oncology Subcommittee of Oncologic Drugs Advisory Committee,Notice,Meeting,2011-10-05T04:00:00Z,2011,10,2011-10-05T04:00:00Z,,2011-10-05T17:12:13Z,2011-25684,0,0,0900006480f4c0fd
FDA-2011-N-0002-0123,FDA,FDA-2011-N-0002,"Preparation for International Conference on Harmonization Steering Committee and Expert Working Group Meetings in Seville, Spain; Regional Public Meeting and Expert Working Group Meetings",Notice,Meeting,2011-10-04T04:00:00Z,2011,10,2011-10-04T04:00:00Z,,2012-04-17T15:16:13Z,2011-25480,0,0,0900006480f4b6d1
FDA-2011-N-0002-0122,FDA,FDA-2011-N-0002,National Mammography Quality Assurance Advisory Committee Notice of Meeting,Notice,Meeting,2011-09-30T04:00:00Z,2011,9,2011-09-30T04:00:00Z,,2011-09-30T12:52:00Z,2011-25148,0,0,0900006480f45a42
FDA-2011-N-0002-0120,FDA,FDA-2011-N-0002,Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives: Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committee,Notice,General Notice,2011-09-29T04:00:00Z,2011,9,2011-09-29T04:00:00Z,,2011-09-29T13:47:45Z,2011-25120,0,0,0900006480f429be
FDA-2011-N-0002-0121,FDA,FDA-2011-N-0002,Meetings: Food Defense Workshop,Notice,Meeting,2011-09-29T04:00:00Z,2011,9,2011-09-29T04:00:00Z,,2011-09-29T14:05:23Z,2011-25114,0,0,0900006480f429f4
FDA-2011-N-0002-0118,FDA,FDA-2011-N-0002,Anti-Infective Drugs Advisory Committee,Notice,Meeting,2011-09-26T04:00:00Z,2011,9,2011-09-26T04:00:00Z,,2011-09-26T14:33:16Z,2011-24601,0,0,0900006480f2bd53
FDA-2011-N-0002-0116,FDA,FDA-2011-N-0002,Gastrointestinal Drugs Advisory Committee,Notice,Meeting,2011-09-26T04:00:00Z,2011,9,2011-09-26T04:00:00Z,,2011-09-26T14:21:00Z,2011-24603,0,0,0900006480f2be2e
FDA-2011-N-0002-0119,FDA,FDA-2011-N-0002,Meetings: Anti-Infective Drugs Advisory Committee,Notice,Meeting,2011-09-26T04:00:00Z,2011,9,2011-09-26T04:00:00Z,,2011-09-26T14:38:06Z,2011-24600,0,0,0900006480f2bd99
FDA-2011-N-0002-0117,FDA,FDA-2011-N-0002,Allergenic Products Advisory Committee,Notice,Meeting,2011-09-26T04:00:00Z,2011,9,2011-09-26T04:00:00Z,,2011-09-26T14:27:31Z,2011-24597,0,0,0900006480f2bd80
FDA-2011-N-0002-0115,FDA,FDA-2011-N-0002,Gastrointestinal Drugs Advisory Committee,Notice,Meeting,2011-09-26T04:00:00Z,2011,9,2011-09-26T04:00:00Z,,2011-09-26T14:16:22Z,2011-24602,0,0,0900006480f2bd4e
FDA-2011-N-0002-0114,FDA,FDA-2011-N-0002,Joint of Meeting Advisory Committee for Reproductive Health Drugs and Drug Safety and Risk Management Advisory Committee; Notice of Meeting,Notice,Meeting,2011-09-23T04:00:00Z,2011,9,,,2011-09-23T13:14:40Z,2011-24532,0,0,0900006480f28469
FDA-2011-N-0002-0113,FDA,FDA-2011-N-0002,Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting,Notice,Meeting,2011-09-23T04:00:00Z,2011,9,,,2011-09-23T13:15:28Z,2011-24533,0,0,0900006480f2843a
FDA-2011-N-0002-0111,FDA,FDA-2011-N-0002,Meetings: Pediatric Oncology Subcommittee of Oncologic Drugs Advisory Committee,Notice,Meeting,2011-09-21T04:00:00Z,2011,9,,,2011-09-21T13:40:57Z,2011-24162,0,0,0900006480f256ed
FDA-2011-N-0002-0112,FDA,FDA-2011-N-0002,Meetings: Risk Communication Advisory Committee,Notice,Meeting,2011-09-21T04:00:00Z,2011,9,,,2011-09-21T13:44:11Z,2011-24168,0,0,0900006480f25766
FDA-2011-N-0002-0110,FDA,FDA-2011-N-0002,Circulatory System Devices Panel of the Medical Devices Advisory Committee,Notice,Meeting,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T15:27:18Z,2011-23875,0,0,0900006480f22152
FDA-2011-N-0002-0109,FDA,FDA-2011-N-0002,Tobacco Products Scientific Advisory Committee,Notice,Meeting,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T15:21:33Z,2011-23868,0,0,0900006480f2207e
FDA-2011-N-0002-0108,FDA,FDA-2011-N-0002,International Conference on Harmonisation Q10 Pharmaceutical Quality System; Meetings: A Practical Approach to Effective Life-Cycle Implementation of Systems and Processes for Pharmaceutical Manufacturing,Notice,Meeting,2011-09-16T04:00:00Z,2011,9,,,2011-09-16T13:24:59Z,2011-23747,0,0,0900006480f1edd0
FDA-2011-N-0002-0107,FDA,FDA-2011-N-0002,Meetings: FDA/Xavier University Global Outsourcing Conference,Notice,Public Meetings,2011-09-14T04:00:00Z,2011,9,2011-09-14T04:00:00Z,,2011-09-14T15:25:28Z,2011-23482,0,0,0900006480f195c2
FDA-2011-N-0002-0106,FDA,FDA-2011-N-0002,Request for Nominations for Nonvoting Industry Representatives on the Tobacco Products Scientific Advisory Committee,Notice,Meeting,2011-09-12T04:00:00Z,2011,9,2011-09-12T04:00:00Z,,2011-09-12T13:46:39Z,2011-23185,0,0,0900006480f16dd6
FDA-2011-N-0002-0105,FDA,FDA-2011-N-0002,Meetings: Circulatory System Devices Panel of the Medical Devices Advisory Committee,Notice,Meeting,2011-09-12T04:00:00Z,2011,9,2011-09-12T04:00:00Z,,2011-09-12T13:32:34Z,2011-23130,0,0,0900006480f16d69
FDA-2011-N-0002-0104,FDA,FDA-2011-N-0002,Health Professional Organizations; Notice of public Conference,Notice,Meeting,2011-09-09T04:00:00Z,2011,9,,,2011-09-09T14:29:04Z,2011-23101,0,0,0900006480f14dbb
FDA-2011-N-0002-0103,FDA,FDA-2011-N-0002,Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2011-09-08T04:00:00Z,2011,9,,,2011-09-08T15:08:02Z,2011-22863,0,0,0900006480f13f17
FDA-2011-N-0002-0102,FDA,FDA-2011-N-0002,Meetings: Vaccines and Related Biological Products Advisory Committee,Notice,Meeting,2011-09-07T04:00:00Z,2011,9,2011-09-07T04:00:00Z,,2011-09-07T19:27:39Z,2011-22766,0,0,0900006480f13033
FDA-2011-N-0002-0101,FDA,FDA-2011-N-0002,Meetings: Immunology Devices Panel of the Medical Devices Advisory Committee; Postponement,Notice,Meeting Postponement,2011-09-07T04:00:00Z,2011,9,2011-09-07T04:00:00Z,,2011-09-07T19:22:18Z,2011-22767,0,0,0900006480f12f73
FDA-2011-N-0002-0100,FDA,FDA-2011-N-0002,Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee,Notice,General Notice,2011-09-02T04:00:00Z,2011,9,2011-09-02T04:00:00Z,,2011-09-02T13:25:24Z,2011-22548,0,0,0900006480f0f06f
FDA-2011-N-0002-0099,FDA,FDA-2011-N-0002,Advisory Committee; Change of Name and Function: Technical Amendment,Rule,Final Rule,2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T14:34:08Z,2011-22105,0,0,0900006480f08cf5
FDA-2011-N-0002-0098,FDA,FDA-2011-N-0002,Meetings: Vaccines and Related Biological Products Advisory Committee,Notice,General Notice,2011-08-23T04:00:00Z,2011,8,2011-08-23T04:00:00Z,,2011-08-23T14:36:24Z,2011-21535,0,0,0900006480eea0a9
FDA-2011-N-0002-0097,FDA,FDA-2011-N-0002,Meetings: Arthritis Advisory Committee; Postponement,Notice,General Notice,2011-08-22T04:00:00Z,2011,8,2011-08-22T04:00:00Z,,2011-08-22T14:09:15Z,2011-21380,0,0,0900006480ee8453
FDA-2011-N-0002-0096,FDA,FDA-2011-N-0002,Dialogues in Diversifying Clinical Trials: Successful Strategies for Engaging Women and Minorities in Clinical Trials,Notice,Meeting,2011-08-18T04:00:00Z,2011,8,2011-08-18T04:00:00Z,,2011-08-25T17:37:43Z,2011-21042,0,0,0900006480ee433e
FDA-2011-N-0002-0094,FDA,FDA-2011-N-0002,"Workshops: Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice",Notice,Meeting,2011-08-17T04:00:00Z,2011,8,,,2011-08-17T14:37:59Z,2011-20858,0,0,0900006480ee30c7
FDA-2011-N-0002-0095,FDA,FDA-2011-N-0002,Workshops: Hemoglobin Standards and Maintaining Adequate Iron Stores in Blood Donors,Notice,Meeting,2011-08-17T04:00:00Z,2011,8,,,2011-08-17T14:44:00Z,2011-20861,0,0,0900006480ee3163
FDA-2011-N-0002-0093,FDA,FDA-2011-N-0002,Meetings: 2011 Parenteral Drug Association/FDA Joint Public Conference; Quality and Compliance in Today's Regulatory Enforcement Environment,Notice,Meeting,2011-08-16T04:00:00Z,2011,8,2011-08-16T04:00:00Z,,2011-08-16T15:08:24Z,2011-20791,0,0,0900006480ee22e1
FDA-2011-N-0002-0092,FDA,FDA-2011-N-0002,Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee,Notice,General Notice,2011-08-15T04:00:00Z,2011,8,2011-08-15T04:00:00Z,,2011-08-15T14:41:32Z,2011-20644,0,0,0900006480ee0d94
FDA-2011-N-0002-0090,FDA,FDA-2011-N-0002,Development and Evaluation of Next-Generation Smallpox Vaccines: Piblic Workshop,Notice,Meeting,2011-08-11T04:00:00Z,2011,8,,,2011-10-25T18:58:54Z,2011-20367,0,0,0900006480edde79
FDA-2011-N-0002-0091,FDA,FDA-2011-N-0002,"Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting",Notice,Meeting,2011-08-11T04:00:00Z,2011,8,,,2011-08-11T13:51:57Z,2011-20399,0,0,0900006480edde97
FDA-2011-N-0002-0089,FDA,FDA-2011-N-0002,"Food and Drug Administration/National Heart, Lung, and Blood Institute/National Science Foundation Public Workshop on Computer Methods for Medical Devices",Notice,Meeting,2011-08-11T04:00:00Z,2011,8,,,2011-08-11T13:44:18Z,2011-20446,0,0,0900006480edddcf
FDA-2011-N-0002-0088,FDA,FDA-2011-N-0002,Meetings: Immunology Devices Panel of the Medical Devices Advisory Committee,Notice,Meeting,2011-08-09T04:00:00Z,2011,8,2011-08-09T04:00:00Z,,2011-08-09T13:49:42Z,2011-20118,0,0,0900006480edba39
FDA-2011-N-0002-0087,FDA,FDA-2011-N-0002,Meetings: Pediatric Advisory Committee,Notice,Meeting,2011-08-02T04:00:00Z,2011,8,2011-08-02T04:00:00Z,,2011-08-02T12:52:17Z,2011-19481,0,0,0900006480ed3883
FDA-2011-N-0002-0085,FDA,FDA-2011-N-0002,Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives: Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committee,Notice,General Notice,2011-07-29T04:00:00Z,2011,7,,,2011-07-29T13:18:20Z,2011-19065,0,0,0900006480ecf452
FDA-2011-N-0002-0083,FDA,FDA-2011-N-0002,Medical Imaging Drugs Advisory Committee; Re-establishment,Rule,Final Rule,2011-07-29T04:00:00Z,2011,7,,,2011-07-29T13:13:02Z,2011-19064,0,0,0900006480ecf3fc
FDA-2011-N-0002-0084,FDA,FDA-2011-N-0002,Request for Nominations for Members: Medical Imaging Drugs Advisory Committee,Notice,General Notice,2011-07-29T04:00:00Z,2011,7,,,2011-07-29T13:15:58Z,2011-19067,0,0,0900006480ecf44d
FDA-2011-N-0002-0086,FDA,FDA-2011-N-0002,Request for Notification From Consumer Organizations Interested in Participating in the Selection Process for Nominations for Voting and/or Nonvoting Consumer Representatives: Request for Nominations for Voting and/or Nonvoting Consumer Representatives on Public Advisory Committees or Panels,Notice,General Notice,2011-07-29T04:00:00Z,2011,7,,,2011-07-29T13:20:07Z,2011-19066,0,0,0900006480ecf480
FDA-2011-N-0002-0081,FDA,FDA-2011-N-0002,"Center for Drug Evaluation and Research, Approach to Addressing Drug Shortage; Public Workshop",Notice,Meeting,2011-07-28T04:00:00Z,2011,7,,,2011-07-28T13:39:12Z,2011-19031,0,0,0900006480ece387
FDA-2011-N-0002-0082,FDA,FDA-2011-N-0002,Review and Qualification of Clinical Outcome Assessments; Public Workshop,Notice,Meeting,2011-07-28T04:00:00Z,2011,7,,,2011-07-28T13:45:58Z,2011-19140,0,0,0900006480ece3b3
FDA-2011-N-0002-0079,FDA,FDA-2011-N-0002,Meetings: Oncologic Drugs Advisory Committee,Notice,Meeting,2011-07-26T04:00:00Z,2011,7,2011-07-26T04:00:00Z,,2011-07-26T15:17:38Z,2011-18877,0,0,0900006480ecb702
FDA-2011-N-0002-0080,FDA,FDA-2011-N-0002,Meetings: Peripheral and Central Nervous System Drugs Advisory Committee,Notice,Meeting,2011-07-26T04:00:00Z,2011,7,2011-07-26T04:00:00Z,,2011-07-26T15:28:13Z,2011-18875,0,0,0900006480ecb743
FDA-2011-N-0002-0076,FDA,FDA-2011-N-0002,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,Meeting,2011-07-22T04:00:00Z,2011,7,2011-07-22T04:00:00Z,,2011-07-22T14:57:35Z,2011-18506,0,0,0900006480ec8c99
FDA-2011-N-0002-0077,FDA,FDA-2011-N-0002,Thirteenth International Paul-Ehrlich-Seminar; Allergen Products for Diagnosis and Therapy; Regulation and Science; Notice of Meeting,Notice,Meeting,2011-07-22T04:00:00Z,2011,7,2011-07-22T04:00:00Z,,2011-07-22T15:00:36Z,2011-18534,0,0,0900006480ec8cd5
FDA-2011-N-0002-0078,FDA,FDA-2011-N-0002,Risk Communication Advisory Committee; Notice of Meeting,Notice,Meeting,2011-07-22T04:00:00Z,2011,7,2011-07-22T04:00:00Z,,2011-07-22T15:03:14Z,2011-18507,0,0,0900006480ec8cf3
FDA-2011-N-0002-0074,FDA,FDA-2011-N-0002,Public Workshops: Quarantine Release Errors in Blood Establishments,Notice,Meeting,2011-07-19T04:00:00Z,2011,7,2011-07-19T04:00:00Z,,2011-07-19T14:32:05Z,2011-18093,0,0,0900006480ec619e
FDA-2011-N-0002-0073,FDA,FDA-2011-N-0002,Meetings: Science Board Advisory Committee,Notice,Meeting,2011-07-19T04:00:00Z,2011,7,2011-07-19T04:00:00Z,,2011-07-19T14:25:41Z,2011-18063,0,0,0900006480ec615d
FDA-2011-N-0002-0075,FDA,FDA-2011-N-0002,Meetings: Arthritis Advisory Committee,Notice,Meeting,2011-07-19T04:00:00Z,2011,7,2011-07-19T04:00:00Z,,2011-07-19T14:37:25Z,2011-18062,0,0,0900006480ec61b4
FDA-2011-N-0002-0072,FDA,FDA-2011-N-0002,Public Workshops: Effects of Ischemia Reperfusion Injury on Outcomes in Kidney Transplantation,Notice,Meeting,2011-07-19T04:00:00Z,2011,7,2011-07-19T04:00:00Z,,2011-07-19T14:10:55Z,2011-18095,0,0,0900006480ec6129
FDA-2011-N-0002-0071,FDA,FDA-2011-N-0002,Obstetrics and Gynecology Devices Panel of Medical Devices Advisory Committee: Notice of Meeting,Notice,Meeting,2011-07-14T04:00:00Z,2011,7,,,2012-10-12T12:48:41Z,2011-17695,0,0,0900006480ec1c9f
FDA-2011-N-0002-0070,FDA,FDA-2011-N-0002,Meetings: Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee,Notice,Meeting,2011-07-11T04:00:00Z,2011,7,2011-07-11T04:00:00Z,,2011-07-11T13:46:30Z,2011-17271,0,0,0900006480ebef46
FDA-2011-N-0002-0069,FDA,FDA-2011-N-0002,"CDRH Town Hall Meeting dated May 5, 2011 - Transcript",Other,Transcript(s),2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2011-07-08T18:41:54Z,,0,0,0900006480ebd017
FDA-2011-N-0002-0068,FDA,FDA-2011-N-0002,Meetings: Design of Clinical Trials for Systemic Antibacterial Drugs for Treatment of Acute Otitis Media; Public Workshop,Notice,Meeting,2011-07-07T04:00:00Z,2011,7,2011-07-07T04:00:00Z,,2011-07-07T15:11:58Z,2011-16962,0,0,0900006480ebb6fe
FDA-2011-N-0002-0067,FDA,FDA-2011-N-0002,Request for Notification From IndustryOrganizations Interested in Participating in the Selection Process for a Nonvoting Industry Representative,Notice,General Notice,2011-07-06T04:00:00Z,2011,7,2011-07-06T04:00:00Z,,2011-07-06T18:45:04Z,2011-16828,0,0,0900006480eba1bc
FDA-2011-N-0002-0065,FDA,FDA-2011-N-0002,Meetings: Blood Products Advisory Committee,Notice,Meeting,2011-07-06T04:00:00Z,2011,7,2011-07-06T04:00:00Z,,2011-07-06T18:39:20Z,2011-16859,0,0,0900006480eba102
FDA-2011-N-0002-0066,FDA,FDA-2011-N-0002,Meetings: Cardiovascular and Renal Drugs Advisory Committee,Notice,Meeting,2011-07-06T04:00:00Z,2011,7,2011-07-06T04:00:00Z,,2011-07-06T18:36:53Z,2011-16862,0,0,0900006480eba15b
FDA-2011-N-0002-0062,FDA,FDA-2011-N-0002,Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting,Notice,Meeting,2011-07-01T04:00:00Z,2011,7,2011-07-01T04:00:00Z,,2011-07-01T14:42:46Z,2011-16576,0,0,0900006480eb8313
FDA-2011-N-0002-0061,FDA,FDA-2011-N-0002,Transmissible Spongiform Encephalopathies Advisory Committee; Notice of Meeting,Notice,Meeting,2011-07-01T04:00:00Z,2011,7,2011-07-01T04:00:00Z,,2011-07-01T14:25:41Z,2011-16574,0,0,0900006480eb82cd
FDA-2011-N-0002-0059,FDA,FDA-2011-N-0002,Meetings: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology,Notice,Meeting,2011-06-29T04:00:00Z,2011,6,2011-06-29T04:00:00Z,,2011-06-29T16:53:00Z,2011-16234,0,0,0900006480eb641c
FDA-2011-N-0002-0056,FDA,FDA-2011-N-0002,Joint Meeting of the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees; Notice of Meeting,Notice,Meeting,2011-06-24T04:00:00Z,2011,6,2011-06-24T04:00:00Z,,2011-06-24T18:31:23Z,2011-15823,0,0,0900006480eb33e4
FDA-2011-N-0002-0055,FDA,FDA-2011-N-0002,Meetings: Circulatory System Devices Panel of Medical Devices Advisory Committee,Notice,Meeting,2011-06-22T04:00:00Z,2011,6,2011-06-22T04:00:00Z,,2011-06-22T15:11:43Z,2011-15539,0,0,0900006480e8c512
FDA-2011-N-0002-0054,FDA,FDA-2011-N-0002,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2011-06-17T04:00:00Z,2011,6,2011-06-17T04:00:00Z,,2011-06-17T14:01:36Z,2011-15019,0,0,0900006480e52099